NR3C1, nuclear receptor subfamily 3 group C member 1, 2908
N. diseases: 590; N. variants: 59
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.080 | 5 | 143281905 | missense variant | A/G | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases | 0.810 | 1.000 | 15 | 1991 | 2019 | ||||||||
|
1.000 | 0.080 | 5 | 143310135 | missense variant | C/T | snv | 4.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases | 0.810 | 1.000 | 15 | 1991 | 2016 | |||||||
|
1.000 | 0.080 | 5 | 143282714 | missense variant | C/T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases | 0.810 | 1.000 | 15 | 1991 | 2016 | ||||||||
|
0.925 | 0.160 | 5 | 143295561 | missense variant | T/A | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases | 0.800 | 1.000 | 14 | 1991 | 2016 | ||||||||
|
0.925 | 0.160 | 5 | 143300556 | missense variant | A/T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases | 0.800 | 1.000 | 14 | 1991 | 2016 | ||||||||
|
1.000 | 0.080 | 5 | 143281982 | missense variant | A/C;G | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases | 0.800 | 1.000 | 14 | 1991 | 2016 | ||||||||
|
1.000 | 0.080 | 5 | 143282014 | missense variant | A/G | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases | 0.800 | 1.000 | 14 | 1991 | 2016 | ||||||||
|
5 | 143335077 | intron variant | C/A | snv | 7.8E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
5 | 143335077 | intron variant | C/A | snv | 7.8E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
1.000 | 0.080 | 5 | 143282038 | missense variant | C/T | snv | 7.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases | 0.700 | 0 | ||||||||||
|
1.000 | 0.080 | 5 | 143300520 | missense variant | A/G | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases | 0.700 | 0 | |||||||||||
|
5 | 143281964 | missense variant | T/A | snv |
|
0.700 | 0 | ||||||||||||||
|
1.000 | 0.080 | 5 | 143298666 | splice donor variant | CTCA/- | delins |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases | 0.700 | 0 | |||||||||||
|
0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.070 | 0.714 | 7 | 2001 | 2010 | |||||||
|
0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 |
|
Nutritional and Metabolic Diseases | 0.050 | 1.000 | 5 | 2005 | 2016 | |||||||
|
0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 |
|
Endocrine System Diseases | 0.040 | 1.000 | 4 | 2012 | 2020 | |||||||
|
0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.040 | 0.750 | 4 | 2003 | 2015 | |||||||
|
0.695 | 0.440 | 5 | 143399010 | intron variant | G/C | snv | 0.31 |
|
Mental Disorders | 0.030 | 1.000 | 3 | 2010 | 2016 | |||||||
|
0.695 | 0.440 | 5 | 143399010 | intron variant | G/C | snv | 0.31 |
|
Mental Disorders | 0.030 | 1.000 | 3 | 2012 | 2018 | |||||||
|
0.695 | 0.440 | 5 | 143399010 | intron variant | G/C | snv | 0.31 |
|
Behavior and Behavior Mechanisms | 0.030 | 1.000 | 3 | 2012 | 2018 | |||||||
|
0.695 | 0.440 | 5 | 143399010 | intron variant | G/C | snv | 0.31 |
|
Behavior and Behavior Mechanisms | 0.030 | 1.000 | 3 | 2012 | 2018 | |||||||
|
0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.030 | 0.667 | 3 | 2005 | 2013 | |||||||
|
0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 |
|
Cardiovascular Diseases | 0.030 | 0.667 | 3 | 2001 | 2013 | |||||||
|
0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 |
|
Endocrine System Diseases | 0.030 | 1.000 | 3 | 2012 | 2020 | |||||||
|
0.595 | 0.680 | 5 | 143399752 | missense variant | T/A;C | snv | 2.0E-02 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.030 | 1.000 | 3 | 2012 | 2016 |